Skip to main content
Top
Published in: Inflammation 3/2016

01-06-2016 | ORIGINAL ARTICLE

Piperine Augments the Protective Effect of Curcumin Against Lipopolysaccharide-Induced Neurobehavioral and Neurochemical Deficits in Mice

Authors: Ashok Jangra, Mohit Kwatra, Tavleen Singh, Rajat Pant, Pawan Kushwah, Yogita Sharma, Babita Saroha, Ashok Kumar Datusalia, Babul Kumar Bezbaruah

Published in: Inflammation | Issue 3/2016

Login to get access

Abstract

The aim of the present study was to investigate the protective effects of curcumin alone and in combination with piperine against lipopolysaccharide (LPS)-induced neurobehavioral and neurochemical deficits in the mice hippocampus. Mice were treated with curcumin (100, 200, and 400 mg/kg, p.o.) and piperine (20 mg/kg, p.o.) for 7 days followed by LPS (0.83 mg/kg, i.p.) administration. Animals exhibited anxiety and depressive-like phenotype after 3 and 24 h of LPS exposure, respectively. LPS administration increased the oxido-nitrosative stress as evident by elevated levels of malondialdehyde, nitrite, and depletion of glutathione level in the hippocampus. Furthermore, we found raised level of pro-inflammatory cytokines (IL-1β and TNF-α) in the hippocampus of LPS-treated mice. Pretreatment with curcumin alleviated LPS-induced neurobehavioral and neurochemical deficits. Furthermore, co-administration of curcumin with piperine significantly potentiated the neuroprotective effect of curcumin. These results demonstrate that piperine enhanced the neuroprotective effect of curcumin against LPS-induced neurobehavioral and neurochemical deficits.
Literature
1.
go back to reference Jangra, A., M.M. Lukhi, K. Sulakhiya, et al. 2014. Protective effect of mangiferin against lipopolysaccharide-induced depressive and anxiety-like behaviour in mice. European Journal of Pharmacology 740: 337–345.CrossRefPubMed Jangra, A., M.M. Lukhi, K. Sulakhiya, et al. 2014. Protective effect of mangiferin against lipopolysaccharide-induced depressive and anxiety-like behaviour in mice. European Journal of Pharmacology 740: 337–345.CrossRefPubMed
3.
go back to reference Hurley, L.L., and Y. Tizabi. 2013. Neuroinflammation, neurodegeneration, and depression. Neurotoxicology Research 23: 131–144.CrossRef Hurley, L.L., and Y. Tizabi. 2013. Neuroinflammation, neurodegeneration, and depression. Neurotoxicology Research 23: 131–144.CrossRef
4.
go back to reference Uher, R., O. Mors, M. Rietschel, et al. 2011. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. Journal of Clinical Psychiatry 72: 1478–1484.CrossRefPubMed Uher, R., O. Mors, M. Rietschel, et al. 2011. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. Journal of Clinical Psychiatry 72: 1478–1484.CrossRefPubMed
5.
go back to reference Sriram, C.S., A. Jangra, S.S. Gurjar, et al. 2015. Poly (ADP-ribose) polymerase-1 inhibitor, 3-aminobenzamide pretreatment ameliorates lipopolysaccharide-induced neurobehavioral and neurochemical anomalies in mice. Pharmacology Biochemistry Behavior 133: 83–91.CrossRef Sriram, C.S., A. Jangra, S.S. Gurjar, et al. 2015. Poly (ADP-ribose) polymerase-1 inhibitor, 3-aminobenzamide pretreatment ameliorates lipopolysaccharide-induced neurobehavioral and neurochemical anomalies in mice. Pharmacology Biochemistry Behavior 133: 83–91.CrossRef
6.
go back to reference Manji, H.K., W.C. Drevets, and D.S. Charney. 2001. The cellular neurobiology of depression. Nature Medicine 7: 541–547.CrossRefPubMed Manji, H.K., W.C. Drevets, and D.S. Charney. 2001. The cellular neurobiology of depression. Nature Medicine 7: 541–547.CrossRefPubMed
7.
go back to reference Maes, M., R. Yirmyia, J. Noraberg, et al. 2009. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metabolic Brain Disease 24: 27–53.CrossRefPubMed Maes, M., R. Yirmyia, J. Noraberg, et al. 2009. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metabolic Brain Disease 24: 27–53.CrossRefPubMed
9.
go back to reference Leonard, B., and M. Maes. 2012. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neuroscience & Biobehavioral Reviews 36: 764–785.CrossRef Leonard, B., and M. Maes. 2012. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neuroscience & Biobehavioral Reviews 36: 764–785.CrossRef
10.
go back to reference Liu, Y., R.C. Ho, and A. Mak. 2012. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. Journal of Affective Disorders 139: 230–239.CrossRefPubMed Liu, Y., R.C. Ho, and A. Mak. 2012. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. Journal of Affective Disorders 139: 230–239.CrossRefPubMed
11.
go back to reference Leonard, B.E., and A. Myint. 2006. Inflammation and depression: is there a causal connection with dementia? Neurotoxicology Research 10: 149–60.CrossRef Leonard, B.E., and A. Myint. 2006. Inflammation and depression: is there a causal connection with dementia? Neurotoxicology Research 10: 149–60.CrossRef
13.
go back to reference Song, C., and H. Wang. 2011. Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 35: 760–768.CrossRef Song, C., and H. Wang. 2011. Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 35: 760–768.CrossRef
14.
go back to reference Godbout, J.P., J. Chen, J. Abraham, et al. 2005. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB Journal 19: 1329–1331.PubMed Godbout, J.P., J. Chen, J. Abraham, et al. 2005. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB Journal 19: 1329–1331.PubMed
15.
go back to reference Huang, Y., C.J. Henry, R. Dantzer, et al. 2007. Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiology of Aging 29: 1744–1753.CrossRefPubMedPubMedCentral Huang, Y., C.J. Henry, R. Dantzer, et al. 2007. Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiology of Aging 29: 1744–1753.CrossRefPubMedPubMedCentral
16.
go back to reference Sugino, K., K. Dohi, K. Yamada, et al. 1987. The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. Surgery 101: 746–752.PubMed Sugino, K., K. Dohi, K. Yamada, et al. 1987. The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. Surgery 101: 746–752.PubMed
17.
go back to reference Guan, Z., and J. Fang. 2006. Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behavior and Immunity 20: 64–71.CrossRef Guan, Z., and J. Fang. 2006. Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behavior and Immunity 20: 64–71.CrossRef
18.
go back to reference Singh, S., S. Jamwal, and P. Kumar. 2015. Piperine enhances the protective effect of curcumin against 3-NP induced neurotoxicity: possible neurotransmitters modulation mechanism. Neurochemical Research 40: 1758–1766.CrossRefPubMed Singh, S., S. Jamwal, and P. Kumar. 2015. Piperine enhances the protective effect of curcumin against 3-NP induced neurotoxicity: possible neurotransmitters modulation mechanism. Neurochemical Research 40: 1758–1766.CrossRefPubMed
19.
go back to reference Noorafshan, A., and S. Ashkani-Esfahani. 2013. A review of therapeutic effects of curcumin. Current Pharmaceutical Design 19: 2032–2046.PubMed Noorafshan, A., and S. Ashkani-Esfahani. 2013. A review of therapeutic effects of curcumin. Current Pharmaceutical Design 19: 2032–2046.PubMed
20.
go back to reference Srimal, R.C., and B.N. Dhawan. 1973. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. Journal of Pharmacy and Pharmacology 25: 447–452.CrossRefPubMed Srimal, R.C., and B.N. Dhawan. 1973. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. Journal of Pharmacy and Pharmacology 25: 447–452.CrossRefPubMed
21.
go back to reference Kiso, Y., Y. Suzuki, N. Watanabe, et al. 1983. Antihepatotoxic principles of Curcuma longa rhizomes. Planta Medica 49: 185–187.CrossRefPubMed Kiso, Y., Y. Suzuki, N. Watanabe, et al. 1983. Antihepatotoxic principles of Curcuma longa rhizomes. Planta Medica 49: 185–187.CrossRefPubMed
22.
go back to reference Ruby, A.J., G. Kuttan, K.D. Babu, et al. 1995. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Letter. 94: 79–83.CrossRef Ruby, A.J., G. Kuttan, K.D. Babu, et al. 1995. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Letter. 94: 79–83.CrossRef
23.
go back to reference Venkatesan, N., D. Punithavathi, and V. Arumugam. 2000. Curcumin prevents adriamycin nephrotoxicity in rats. British Journal of Pharmacology 129: 231–234.CrossRefPubMedPubMedCentral Venkatesan, N., D. Punithavathi, and V. Arumugam. 2000. Curcumin prevents adriamycin nephrotoxicity in rats. British Journal of Pharmacology 129: 231–234.CrossRefPubMedPubMedCentral
24.
go back to reference Calabrese, V., T.E. Bates, C. Mancuso, et al. 2008. Curcumin and the cellular stress response in free radical-related diseases. Molecular Nutrition & Food Research 52: 1062–1073.CrossRef Calabrese, V., T.E. Bates, C. Mancuso, et al. 2008. Curcumin and the cellular stress response in free radical-related diseases. Molecular Nutrition & Food Research 52: 1062–1073.CrossRef
25.
go back to reference De, R., P. Kundu, S. Swarnakar, et al. 2009. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrobial Agents and Chemotherapy 53: 1592–1597.CrossRefPubMedPubMedCentral De, R., P. Kundu, S. Swarnakar, et al. 2009. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrobial Agents and Chemotherapy 53: 1592–1597.CrossRefPubMedPubMedCentral
26.
go back to reference Nafisi, S., M. Adelzadeh, Z. Norouzi, et al. 2009. Curcumin binding to DNA and RNA. DNA Cell Biology 28: 201–208.CrossRefPubMed Nafisi, S., M. Adelzadeh, Z. Norouzi, et al. 2009. Curcumin binding to DNA and RNA. DNA Cell Biology 28: 201–208.CrossRefPubMed
27.
go back to reference Xu, Y., D. Lin, S. Li, et al. 2009. Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress. Neuropharmacology 57: 463–71.CrossRefPubMed Xu, Y., D. Lin, S. Li, et al. 2009. Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress. Neuropharmacology 57: 463–71.CrossRefPubMed
28.
go back to reference Mancuso, C., R. Siciliano, E. Barone, et al. 2012. Natural substances and Alzheimer’s disease: from preclinical studies to evidence based medicine. Biochimica et Biophysica Acta 1822: 616–624.CrossRefPubMed Mancuso, C., R. Siciliano, E. Barone, et al. 2012. Natural substances and Alzheimer’s disease: from preclinical studies to evidence based medicine. Biochimica et Biophysica Acta 1822: 616–624.CrossRefPubMed
29.
go back to reference Kumar, A., S. Dogra, and A. Prakash. 2009. Protective effect of curcumin (Curcuma longa), against aluminium toxicity: Possible behavioral and biochemical alterations in rats. Behavioural Brain Research 205: 384–390.CrossRefPubMed Kumar, A., S. Dogra, and A. Prakash. 2009. Protective effect of curcumin (Curcuma longa), against aluminium toxicity: Possible behavioral and biochemical alterations in rats. Behavioural Brain Research 205: 384–390.CrossRefPubMed
30.
go back to reference Pattanaik, S., D. Hota, and S. Prabhakar. 2009. Pharmacokinetic interaction of single dose of piperine with steady-state carbamazepine in epilepsy patients. Phytotherapy Research 23: 1281–1286.CrossRefPubMed Pattanaik, S., D. Hota, and S. Prabhakar. 2009. Pharmacokinetic interaction of single dose of piperine with steady-state carbamazepine in epilepsy patients. Phytotherapy Research 23: 1281–1286.CrossRefPubMed
31.
go back to reference Rinwa, P., and A. Kumar. 2012. Piperine potentiates the protective effects of curcumin against chronic unpredictable stress-induced cognitive impairment and oxidative damage in mice. Brain Research 1488: 38–50.CrossRefPubMed Rinwa, P., and A. Kumar. 2012. Piperine potentiates the protective effects of curcumin against chronic unpredictable stress-induced cognitive impairment and oxidative damage in mice. Brain Research 1488: 38–50.CrossRefPubMed
32.
go back to reference Espejo, E.F. 1997. Effects of weekly or daily exposure to the elevated plus-maze in male mice. Behavioral Brain Research 87: 233–238.CrossRef Espejo, E.F. 1997. Effects of weekly or daily exposure to the elevated plus-maze in male mice. Behavioral Brain Research 87: 233–238.CrossRef
33.
go back to reference Bassi, G.S., A. Kanashiro, F.M. Santin, et al. 2012. Lipopolysaccharide-induced sickness behaviour evaluated in different models of anxiety and innate fear in rats. Basic & Clinical Pharmacology & Toxicology 110: 359–369.CrossRef Bassi, G.S., A. Kanashiro, F.M. Santin, et al. 2012. Lipopolysaccharide-induced sickness behaviour evaluated in different models of anxiety and innate fear in rats. Basic & Clinical Pharmacology & Toxicology 110: 359–369.CrossRef
34.
go back to reference Lacosta, S., Z. Merali, and H. Anisman. 1999. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Research 818: 291–303.CrossRefPubMed Lacosta, S., Z. Merali, and H. Anisman. 1999. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Research 818: 291–303.CrossRefPubMed
35.
go back to reference Steru, L., R. Chermat, B. Thierry, et al. 1985. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85: 367–370.CrossRef Steru, L., R. Chermat, B. Thierry, et al. 1985. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85: 367–370.CrossRef
36.
go back to reference Porsolt, R., A. Bertin, and M. Jalfre. 1977. Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Thérapie 229: 327–336.PubMed Porsolt, R., A. Bertin, and M. Jalfre. 1977. Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Thérapie 229: 327–336.PubMed
37.
go back to reference Jangra, A., A.K. Datusalia, S. Khandwe, et al. 2013. Amelioration of diabetes-induced neurobehavioral and neurochemical changes by melatonin and nicotinamide: implication of oxidative stress-PARP pathway. Pharmacology Biochemistry Behavior 114–115: 43–51.CrossRef Jangra, A., A.K. Datusalia, S. Khandwe, et al. 2013. Amelioration of diabetes-induced neurobehavioral and neurochemical changes by melatonin and nicotinamide: implication of oxidative stress-PARP pathway. Pharmacology Biochemistry Behavior 114–115: 43–51.CrossRef
38.
go back to reference Beutler, E., O. Duron, and B.M. Kelly. 1963. Improved method for the determination of blood glutathione. Journal of Laboratory and Clinical Medicine 61: 882–888.PubMed Beutler, E., O. Duron, and B.M. Kelly. 1963. Improved method for the determination of blood glutathione. Journal of Laboratory and Clinical Medicine 61: 882–888.PubMed
39.
go back to reference Lowry, O.H., N.J. Rosebrough, A.L. Farr, et al. 1951. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 265–275.PubMed Lowry, O.H., N.J. Rosebrough, A.L. Farr, et al. 1951. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 265–275.PubMed
40.
go back to reference Green, L.C., D.A. Wagner, J. Glogowski, et al. 1982. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Analytical Biochemistry 126: 131–138.CrossRefPubMed Green, L.C., D.A. Wagner, J. Glogowski, et al. 1982. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Analytical Biochemistry 126: 131–138.CrossRefPubMed
41.
go back to reference Maes, M. 1995. Evidence for an immune response in major depression: a review and hypothesis. Progress in Neuro-Psychopharmacology & Biological Psychiatry 19: 11–38.CrossRef Maes, M. 1995. Evidence for an immune response in major depression: a review and hypothesis. Progress in Neuro-Psychopharmacology & Biological Psychiatry 19: 11–38.CrossRef
42.
go back to reference Dunbar, P., J. Hill, T. Neale, et al. 1992. Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia. Psychological Medicine 22: 1051–1057.CrossRefPubMed Dunbar, P., J. Hill, T. Neale, et al. 1992. Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia. Psychological Medicine 22: 1051–1057.CrossRefPubMed
43.
go back to reference Hestad, K.A., S. Tønseth, C.D. Støen, et al. 2003. Raised plasma levels of tumor necrosis factor [alpha] in patients with depression: normalization during electroconvulsive therapy. Journal ECT 19: 183–188.CrossRef Hestad, K.A., S. Tønseth, C.D. Støen, et al. 2003. Raised plasma levels of tumor necrosis factor [alpha] in patients with depression: normalization during electroconvulsive therapy. Journal ECT 19: 183–188.CrossRef
44.
go back to reference Moylan, S., M. Maes, N.R. Wray, et al. 2012. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Molecular Psychiatry 18: 595–606.CrossRefPubMed Moylan, S., M. Maes, N.R. Wray, et al. 2012. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Molecular Psychiatry 18: 595–606.CrossRefPubMed
45.
go back to reference Swiergiel, A.H., and A.J. Dunn. 2007. Effects of interleukin-1β and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacology Biochemistry Behavior 86: 651–659.CrossRef Swiergiel, A.H., and A.J. Dunn. 2007. Effects of interleukin-1β and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacology Biochemistry Behavior 86: 651–659.CrossRef
46.
go back to reference Biesmans, S., T.F. Meert, J.A. Bouwknecht, et al. 2013. Systemic immune activation leads to neuroinflammation and sickness behavior in mice. Mediators of inflammation 2013:2013:271359. Biesmans, S., T.F. Meert, J.A. Bouwknecht, et al. 2013. Systemic immune activation leads to neuroinflammation and sickness behavior in mice. Mediators of inflammation 2013:2013:271359.
47.
go back to reference Sriram, C.S., A. Jangra, S.S. Gurjar, et al. 2016. Edaravone abrogates LPS-induced behavioral anomalies, neuroinflammation and PARP-1. Physiology Behavior. 154: 135–144.CrossRefPubMed Sriram, C.S., A. Jangra, S.S. Gurjar, et al. 2016. Edaravone abrogates LPS-induced behavioral anomalies, neuroinflammation and PARP-1. Physiology Behavior. 154: 135–144.CrossRefPubMed
48.
go back to reference Sulakhiya, K., G.P. Keshavlal, B.B. Bezbaruah, et al. 2016. Lipopolysaccharide induced anxiety- and depressive-like behaviour in mice are prevented by chronic pre-treatment of esculetin. Neuroscience Letters 611: 106–111.CrossRefPubMed Sulakhiya, K., G.P. Keshavlal, B.B. Bezbaruah, et al. 2016. Lipopolysaccharide induced anxiety- and depressive-like behaviour in mice are prevented by chronic pre-treatment of esculetin. Neuroscience Letters 611: 106–111.CrossRefPubMed
49.
go back to reference Lawson, M.A., J.M. Parrott, R.H. McCusker, et al. 2013. Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors. Journal of Neuroinflammation 10: 87.CrossRefPubMedPubMedCentral Lawson, M.A., J.M. Parrott, R.H. McCusker, et al. 2013. Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors. Journal of Neuroinflammation 10: 87.CrossRefPubMedPubMedCentral
50.
go back to reference Dantzer, R., J.C. O’Connor, G.G. Freund, et al. 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Review of Neuroscience 9: 46–56.CrossRef Dantzer, R., J.C. O’Connor, G.G. Freund, et al. 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Review of Neuroscience 9: 46–56.CrossRef
51.
go back to reference O’Connor, J.C., M.A. Lawson, C. André, et al. 2009. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Molecular Psychiatry 14: 511–522.CrossRefPubMedPubMedCentral O’Connor, J.C., M.A. Lawson, C. André, et al. 2009. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Molecular Psychiatry 14: 511–522.CrossRefPubMedPubMedCentral
52.
go back to reference Walker, A.K., D.P. Budac, S. Bisulco, et al. 2013. NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice. Neuropsychopharmacology 38: 1609–1616.CrossRefPubMedPubMedCentral Walker, A.K., D.P. Budac, S. Bisulco, et al. 2013. NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice. Neuropsychopharmacology 38: 1609–1616.CrossRefPubMedPubMedCentral
53.
go back to reference Berkenbosch, F., J. van Oers, A. del Rey, et al. 1987. Corticotropin-releasing factor producing neurons in the rat activated by interleukin-1. Science 238: 524–526.CrossRefPubMed Berkenbosch, F., J. van Oers, A. del Rey, et al. 1987. Corticotropin-releasing factor producing neurons in the rat activated by interleukin-1. Science 238: 524–526.CrossRefPubMed
54.
go back to reference Reichenberg, A., T. Kraus, M. Haack, et al. 2002. Endotoxin-induced changes in food consumption in healthy volunteers are associated with TNF-alpha and IL-6 secretion. Psychoneuroendocrinology 27: 945–956.CrossRefPubMed Reichenberg, A., T. Kraus, M. Haack, et al. 2002. Endotoxin-induced changes in food consumption in healthy volunteers are associated with TNF-alpha and IL-6 secretion. Psychoneuroendocrinology 27: 945–956.CrossRefPubMed
55.
go back to reference Sulakhiya, K., P. Kumar, A. Jangra, et al. 2014. Honokiol abrogates lipopolysaccharide-induced depressive like behavior by impeding neuroinflammation and oxido-nitrosative stress in mice. European Journal of Pharmacolology 744: 124–131.CrossRef Sulakhiya, K., P. Kumar, A. Jangra, et al. 2014. Honokiol abrogates lipopolysaccharide-induced depressive like behavior by impeding neuroinflammation and oxido-nitrosative stress in mice. European Journal of Pharmacolology 744: 124–131.CrossRef
56.
go back to reference Jiang, H., Z. Wang, Y. Wang, et al. 2013. Antidepressant-like effects of curcumin in chronic mild stress of rats: involvement of its anti-inflammatory action. Progress in Neuro-Psychopharmacology & Biological Psychiatry 47: 33–39.CrossRef Jiang, H., Z. Wang, Y. Wang, et al. 2013. Antidepressant-like effects of curcumin in chronic mild stress of rats: involvement of its anti-inflammatory action. Progress in Neuro-Psychopharmacology & Biological Psychiatry 47: 33–39.CrossRef
57.
go back to reference Rinwa, P., A. Kumar, and S. Garg. 2013. Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression. PLoS One 8, e61052.CrossRefPubMedPubMedCentral Rinwa, P., A. Kumar, and S. Garg. 2013. Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression. PLoS One 8, e61052.CrossRefPubMedPubMedCentral
58.
go back to reference Sharma, O.P. 1976. Antioxidant activity of curcumin and related compounds. Biochemical Pharmacology 25: 1811–1812.CrossRefPubMed Sharma, O.P. 1976. Antioxidant activity of curcumin and related compounds. Biochemical Pharmacology 25: 1811–1812.CrossRefPubMed
59.
go back to reference Sidhu, G.S., A.K. Singh, D. Thaloor, et al. 1998. Enhancement of wound healing by curcumin in animals. Wound Repair and Regeneration 6: 167–177.CrossRefPubMed Sidhu, G.S., A.K. Singh, D. Thaloor, et al. 1998. Enhancement of wound healing by curcumin in animals. Wound Repair and Regeneration 6: 167–177.CrossRefPubMed
60.
go back to reference Negi, P.S., G.K. Jayaprakasha, R. Jagan Mohan, et al. 1999. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. Journal of Agricultural and Food Chemistry 47: 4297–4300.CrossRefPubMed Negi, P.S., G.K. Jayaprakasha, R. Jagan Mohan, et al. 1999. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. Journal of Agricultural and Food Chemistry 47: 4297–4300.CrossRefPubMed
61.
go back to reference Mukerjee, A., and J.K. Vishwanatha. 2009. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Research 29: 3867–3875.PubMed Mukerjee, A., and J.K. Vishwanatha. 2009. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Research 29: 3867–3875.PubMed
62.
go back to reference Shaikh, J., D.D. Ankola, V. Beniwal, et al. 2009. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. European Journal Pharmaceutical Science 37: 223–230.CrossRef Shaikh, J., D.D. Ankola, V. Beniwal, et al. 2009. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. European Journal Pharmaceutical Science 37: 223–230.CrossRef
63.
go back to reference Takahashi, M., S. Uechi, K. Takara, et al. 2009. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. Journal of Agricultural and Food Chemistry 57: 9141–9146.CrossRefPubMed Takahashi, M., S. Uechi, K. Takara, et al. 2009. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. Journal of Agricultural and Food Chemistry 57: 9141–9146.CrossRefPubMed
64.
go back to reference Klippstein, R., J.T. Wang, R.I. El-Gogary, et al. 2015. Passively targeted curcumin-loaded PEGylated PLGA nanocapsules for colon cancer therapy in vivo. Small 11: 4704–4722.CrossRefPubMedPubMedCentral Klippstein, R., J.T. Wang, R.I. El-Gogary, et al. 2015. Passively targeted curcumin-loaded PEGylated PLGA nanocapsules for colon cancer therapy in vivo. Small 11: 4704–4722.CrossRefPubMedPubMedCentral
65.
go back to reference Anand, P., A.B. Kunnumakkara, R.A. Newman, et al. 2007. Bioavailability of curcumin: problems and promises. Molecular Pharmacology 4: 807–818.CrossRef Anand, P., A.B. Kunnumakkara, R.A. Newman, et al. 2007. Bioavailability of curcumin: problems and promises. Molecular Pharmacology 4: 807–818.CrossRef
66.
go back to reference Kesarwani, K., and R. Gupta. 2013. Bioavailability enhancers of herbal origin: an overview. Asian Pacific Journal of Tropical Biomedicine 3: 253–266.CrossRefPubMedPubMedCentral Kesarwani, K., and R. Gupta. 2013. Bioavailability enhancers of herbal origin: an overview. Asian Pacific Journal of Tropical Biomedicine 3: 253–266.CrossRefPubMedPubMedCentral
67.
go back to reference Rinwa, P., and A. Kumar. 2013. Quercetin along with piperine prevents cognitive dysfunction, oxidative stress and neuro-inflammation associated with mouse model of chronic unpredictable stress. Archives of Pharmacal Research 2013: 2013. Rinwa, P., and A. Kumar. 2013. Quercetin along with piperine prevents cognitive dysfunction, oxidative stress and neuro-inflammation associated with mouse model of chronic unpredictable stress. Archives of Pharmacal Research 2013: 2013.
68.
go back to reference Atal, C.K., R.K. Dubey, and J.J. Singh. 1985. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. Journal of Pharmacology and Experimental Therapeutics 232: 258–262.PubMed Atal, C.K., R.K. Dubey, and J.J. Singh. 1985. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. Journal of Pharmacology and Experimental Therapeutics 232: 258–262.PubMed
69.
go back to reference Prasad, S., A.K. Tyagi, and B.B. Aggarwal. 2014. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Research and Treatment 46: 2–18.CrossRefPubMedPubMedCentral Prasad, S., A.K. Tyagi, and B.B. Aggarwal. 2014. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Research and Treatment 46: 2–18.CrossRefPubMedPubMedCentral
70.
go back to reference Clementi, E., G.C. Brown, M. Feelisch, et al. 1998. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proceedings of the National Academy of Sciences 95: 7631–7636.CrossRef Clementi, E., G.C. Brown, M. Feelisch, et al. 1998. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proceedings of the National Academy of Sciences 95: 7631–7636.CrossRef
71.
go back to reference Jezek, P., and L. Hlavata. 2005. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. International Journal of Biochemistry & Cell Biology 37: 2478–2503.CrossRef Jezek, P., and L. Hlavata. 2005. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. International Journal of Biochemistry & Cell Biology 37: 2478–2503.CrossRef
72.
go back to reference Lijuan, B., X. Zhang, L. Xiaohong, et al. 2015. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia. Molecular Medicine Report 12: 1002–1008. Lijuan, B., X. Zhang, L. Xiaohong, et al. 2015. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia. Molecular Medicine Report 12: 1002–1008.
73.
go back to reference Miller, A.H., V. Maletic, and C.L. Raison. 2009. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological psychiatry 65: 732–741.CrossRefPubMedPubMedCentral Miller, A.H., V. Maletic, and C.L. Raison. 2009. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological psychiatry 65: 732–741.CrossRefPubMedPubMedCentral
74.
go back to reference Betancur, C., J. Borrell, and C. Guaza. 1995. Cytokine regulation of corticosteroid receptors in the rat hippocampus: effects of interleukin-1, interleukin-6, tumor necrosis factor and Lipopolysaccharide. Neuroendocrinology 62: 47–54.CrossRefPubMed Betancur, C., J. Borrell, and C. Guaza. 1995. Cytokine regulation of corticosteroid receptors in the rat hippocampus: effects of interleukin-1, interleukin-6, tumor necrosis factor and Lipopolysaccharide. Neuroendocrinology 62: 47–54.CrossRefPubMed
75.
go back to reference Reincke, M., B. Allolio, G. Würth, et al. 1993. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. Journal of Clinical Endocrinology & Metabolism 77: 151–156. Reincke, M., B. Allolio, G. Würth, et al. 1993. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. Journal of Clinical Endocrinology & Metabolism 77: 151–156.
76.
go back to reference Beishuizen, A., and L.G. Thijs. 2003. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. Journal of Endotoxin Research 9: 3–24.PubMed Beishuizen, A., and L.G. Thijs. 2003. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. Journal of Endotoxin Research 9: 3–24.PubMed
77.
go back to reference Erkut, Z.A., E. Endert, I. Huitinga, et al. 2002. Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis. Multiple Sclerosis 8: 229–236.CrossRefPubMed Erkut, Z.A., E. Endert, I. Huitinga, et al. 2002. Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis. Multiple Sclerosis 8: 229–236.CrossRefPubMed
78.
go back to reference Cubała, W.J., and J. Landowski. 2005. Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression. Psychiatria polska 40: 415–430. Cubała, W.J., and J. Landowski. 2005. Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression. Psychiatria polska 40: 415–430.
79.
go back to reference Sen, S., R. Duman, and G. Sanacora. 2008. Serum BDNF, depression and anti-depressant medications: meta-analyses and implications. Biological Psychiatry 64: 527–532.CrossRefPubMedPubMedCentral Sen, S., R. Duman, and G. Sanacora. 2008. Serum BDNF, depression and anti-depressant medications: meta-analyses and implications. Biological Psychiatry 64: 527–532.CrossRefPubMedPubMedCentral
80.
go back to reference Basterzi, A.D., K. Yazici, E. Aslan, et al. 2009. Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry 33: 281–285.CrossRef Basterzi, A.D., K. Yazici, E. Aslan, et al. 2009. Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry 33: 281–285.CrossRef
81.
go back to reference Varambally, S., G.H. Naveen, M.G. Rao, et al. 2013. Low serum brain derived neurotrophic factor in non-suicidal out-patients with depression: relation to depression scores. Indian Journal of Psychiatry 55(Suppl 3): S397–S399.CrossRefPubMedPubMedCentral Varambally, S., G.H. Naveen, M.G. Rao, et al. 2013. Low serum brain derived neurotrophic factor in non-suicidal out-patients with depression: relation to depression scores. Indian Journal of Psychiatry 55(Suppl 3): S397–S399.CrossRefPubMedPubMedCentral
82.
go back to reference Xu, Y., B.S. Ku, L. Tie, et al. 2006. Curcumin reverses the effects of chronic stress on behavior, the HPA axis. BDNF expression and phosphorylation of CREB. Brain Research. 1122: 56–64.PubMed Xu, Y., B.S. Ku, L. Tie, et al. 2006. Curcumin reverses the effects of chronic stress on behavior, the HPA axis. BDNF expression and phosphorylation of CREB. Brain Research. 1122: 56–64.PubMed
83.
go back to reference Li, S., C. Wang, M. Wang, et al. 2007. Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms. Life Sciences 15: 1373–1381.CrossRef Li, S., C. Wang, M. Wang, et al. 2007. Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms. Life Sciences 15: 1373–1381.CrossRef
84.
go back to reference Jacobsen, J.P., and A. Mørk. 2006. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex of the rat. Brain Research 1110: 221–225.CrossRefPubMed Jacobsen, J.P., and A. Mørk. 2006. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex of the rat. Brain Research 1110: 221–225.CrossRefPubMed
85.
go back to reference Huang, Z., X.M. Zhong, Z.Y. Li, et al. 2011. Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats. Neuroscience Letters 493: 145–148.CrossRefPubMed Huang, Z., X.M. Zhong, Z.Y. Li, et al. 2011. Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats. Neuroscience Letters 493: 145–148.CrossRefPubMed
86.
go back to reference Jangra, A., S. Dwivedi, C.S. Sriram, et al. 2015. Honokiol abrogates chronic restraint stress-induced cognitive impairment and depressive-like behaviour by blocking endoplasmic reticulum stress in the hippocampus of mice. European Journal of Pharmacology 770: 25–32.CrossRefPubMed Jangra, A., S. Dwivedi, C.S. Sriram, et al. 2015. Honokiol abrogates chronic restraint stress-induced cognitive impairment and depressive-like behaviour by blocking endoplasmic reticulum stress in the hippocampus of mice. European Journal of Pharmacology 770: 25–32.CrossRefPubMed
87.
go back to reference Jangra, A., C.S. Sriram, S. Dwivedi, et al. 2016. Sodium Phenylbutyrate and Edaravone Abrogate Chronic Restraint Stress-Induced Behavioral Deficits: Implication of Oxido-Nitrosative, Endoplasmic Reticulum Stress Cascade, and Neuroinflammation. Cellular and Molecular Neurobiology. doi:10.1007/s10571-016-0344-5. Jangra, A., C.S. Sriram, S. Dwivedi, et al. 2016. Sodium Phenylbutyrate and Edaravone Abrogate Chronic Restraint Stress-Induced Behavioral Deficits: Implication of Oxido-Nitrosative, Endoplasmic Reticulum Stress Cascade, and Neuroinflammation. Cellular and Molecular Neurobiology. doi:10.​1007/​s10571-016-0344-5.
Metadata
Title
Piperine Augments the Protective Effect of Curcumin Against Lipopolysaccharide-Induced Neurobehavioral and Neurochemical Deficits in Mice
Authors
Ashok Jangra
Mohit Kwatra
Tavleen Singh
Rajat Pant
Pawan Kushwah
Yogita Sharma
Babita Saroha
Ashok Kumar Datusalia
Babul Kumar Bezbaruah
Publication date
01-06-2016
Publisher
Springer US
Published in
Inflammation / Issue 3/2016
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0332-4

Other articles of this Issue 3/2016

Inflammation 3/2016 Go to the issue